High-Strength Suture vs. Traditional Tension Band for Patellar Fractures

November 21, 2025 updated by: Anning Liu, Fuzhou University Affiliated Provincial Hospital

Prospective Cohort Study of High-Strength Suture Modified Tension Band Technique for the Treatment of Patellar Fractures

This prospective cohort study aims to evaluate the clinical efficacy of high-strength suture modified tension band fixation in treating patellar fractures and compare it with traditional screw-cable tension band fixation. Adult patients (18-55 years) with AO/OTA 34-C1 or 34-C2 patellar fractures will be enrolled and followed for 12 months. Primary outcomes include Lysholm knee function score, knee range of motion (ROM), and visual analog scale (VAS) pain score at 12 months post-surgery. Secondary outcomes include fracture healing time, radiographic alignment quality, complication rates, reoperation rates, implant removal rates, SF-36 health survey scores, and patient satisfaction. No additional biological samples will be collected; data will focus on clinical, radiographic, and follow-up information.

Study Overview

Detailed Description

Patellar fractures account for approximately 1% of all fractures and are common in knee injuries. Traditional tension band fixation is widely used but associated with issues such as hardware migration, soft tissue irritation, and postoperative pain, impacting rehabilitation and quality of life. High-strength sutures offer improved biomechanical properties, flexibility, and reduced soft tissue damage. This study observes the clinical efficacy of high-strength suture modified tension band fixation compared to traditional methods through a prospective cohort design.

Patients admitted to Fuzhou University Affiliated Provincial Hospital from February 2024 to February 2026 with patellar fractures undergoing surgery will be divided into two groups based on surgical method: Suture Fixation (SF) group and Screw-Cable Tension Band (SCTB) group. Follow-up will occur for 12 months, assessing outcomes such as postoperative VAS pain scores, Lysholm knee scores, ROM, SF-36 health surveys, surgical time, intraoperative blood loss, hospital stay, and complications (e.g., infection, fixation failure, nonunion).

General data collected includes demographics (age, gender, height, weight, BMI), comorbidities (e.g., diabetes, hypertension, smoking), ASA classification, fracture details (side, type, displacement, mechanism, time from injury), and perioperative complications. Imaging assessments include fracture reduction quality (good, satisfactory, poor) via X-ray, healing time (weeks until fracture line blurs/disappears), and patellar height via Insall-Salvati index. Muscle strength (quadriceps via MMT, 0-5 grades) and patient satisfaction (1-5 scale) will also be evaluated.

Adverse events (AEs) and serious adverse events (SAEs) will be recorded, reported to the ethics committee, and managed promptly. Statistical analysis will use IBM SPSS Statistics 27.0, with t-tests, Mann-Whitney U tests, chi-square/Fisher's exact tests, Kaplan-Meier curves, and regressions as appropriate. Intention-to-treat (ITT) analysis will be primary, with multiple imputation for missing data.

The study is feasible given the hospital's patient volume and the principal investigator's experience. Ethical principles follow the Helsinki Declaration, with informed consent and privacy protection. Results will be published in academic journals and presented at conferences.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Anning Liu, M.Med. (candidate)
  • Phone Number: +8615259370989
  • Email: jomt852@163.com

Study Locations

    • Fujian
      • Fuzhou, Fujian, China, 350001
        • Recruiting
        • Fuzhou University Affiliated Provincial Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients with patellar fractures seeking surgical treatment at Fuzhou University Affiliated Provincial Hospital, meeting inclusion criteria, and grouped based on surgical technique received.

Description

Inclusion Criteria:

  • 1.Age 18-55 years. 2.Radiographically confirmed patellar fracture (AO/OTA 34-C1 or 34-C2). 3.First-time patellar fracture surgery. 4.Time from injury to surgery ≤ 2 weeks. 5.Able to comply with follow-up and provide written informed consent. 6.Normal pre-injury knee function. 7.Able to tolerate surgery and agree to surgical treatment. 8.Intact cognitive function.

Exclusion Criteria:

  • 1.Age <18 or >55 years. 2.Pathological fractures. 3.Prior patellar surgery or severe underlying patellofemoral disease. 4.Time from injury to surgery >2 weeks. 5.Concurrent active infection or severe medical conditions. 6.Severe neuropsychiatric disorders affecting follow-up compliance. 7.Postmenopausal women. 8.Inability to tolerate surgery or refusal of surgery. 9.Comorbid patellar dysplasia, rheumatoid arthritis, or other patellofemoral diseases.

    10.Comorbid systemic or local infection at surgical site. 11.Comorbid severe lower limb or systemic injuries. 12.Pre-injury cognitive impairment, mental disorder, or independent walking disability.

    13.Other conditions unsuitable for enrollment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Suture Fixation (SF) Group
Patients receiving high-strength suture modified tension band fixation for patellar fracture.
Use of high-strength sutures for modified tension band fixation in patellar fracture surgery.
Other Names:
  • Suture Fixation (SF)
Screw-Cable Tension Band (SCTB) Group
Patients receiving traditional screw-cable tension band fixation for patellar fracture.
Use of screws and cables for traditional modified tension band fixation in patellar fracture surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lysholm Knee Score at 12 Months Postoperatively
Time Frame: 12 months postoperatively
Lysholm knee scoring scale (0-100 points; 95-100 = excellent, 84-94 = good, 65-83 = fair, <65 = poor; higher scores indicate better knee function). Assessed at baseline (pre-injury recalled), 1 week, 1 month, 3 months, 6 months, and 12 months postoperatively.
12 months postoperatively
Knee Range of Motion at 12 Months Postoperatively
Time Frame: 12 months postoperatively
Active knee flexion and extension range of motion measured in degrees with a goniometer (higher values indicate better function). Assessed at 1 week, 1 month, 3 months, 6 months, and 12 months postoperatively.
12 months postoperatively
Visual Analog Scale (VAS) Pain Score at 12 Months Postoperatively
Time Frame: 12 months postoperatively
Visual Analog Scale for pain (0-10 points; 0 = no pain, 10 = worst imaginable pain; higher scores indicate more severe pain). Assessed preoperatively and at 1 week, 1 month, 3 months, 6 months, and 12 months postoperatively.
12 months postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fracture Healing Time
Time Frame: Assessed at 6 weeks, 3 months, 6 months, and 12 months postoperatively or until healing confirmed
Time in weeks from surgery until radiographic evidence of fracture line blurring or disappearance on X-ray/CT.
Assessed at 6 weeks, 3 months, 6 months, and 12 months postoperatively or until healing confirmed
Radiographic Alignment Quality
Time Frame: Immediately postoperatively and at 1 month, 3 months, 6 months, and 12 months postoperatively
Postoperative fracture reduction quality graded as good, satisfactory, or poor based on X-ray.
Immediately postoperatively and at 1 month, 3 months, 6 months, and 12 months postoperatively
Complication Rate
Time Frame: From surgery to 12 months postoperatively
Incidence of any postoperative complications (e.g., infection, fixation failure, nonunion, knee stiffness, deep vein thrombosis).
From surgery to 12 months postoperatively
Reoperation Rate
Time Frame: From surgery to 12 months postoperatively
Percentage of patients requiring any additional surgery related to the index fracture.
From surgery to 12 months postoperatively
Implant Removal Rate
Time Frame: From surgery to 12 months postoperatively
Percentage of patients requiring removal of surgical implants.
From surgery to 12 months postoperatively
SF-36 (36-Item Short Form Health Survey) Score
Time Frame: 12 months postoperatively
36-Item Short Form Health Survey (SF-36) questionnaire assessing health-related quality of life. The SF-36 includes eight domains (physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, mental health); scores for each domain range from 0-100, with higher scores indicating better health status. The Physical Component Summary (PCS) and Mental Component Summary (MCS) will also be calculated and reported. Assessed at 12 months postoperatively.
12 months postoperatively
Surgical Time
Time Frame: Day of surgery
Duration of the surgical procedure recorded in minutes from skin incision to closure.
Day of surgery
Intraoperative Blood Loss
Time Frame: Day of surgery
Estimated volume of blood loss during surgery recorded in milliliters.
Day of surgery
Hospital Stay Duration
Time Frame: From day of surgery to discharge
Number of days from the date of surgery to the date of hospital discharge.
From day of surgery to discharge
Quadriceps Muscle Strength (Manual Muscle Testing)
Time Frame: Assessed at 1 week, 1 month, 3 months, 6 months, and 12 months postoperatively
Quadriceps strength graded 0-5 using Manual Muscle Testing (MMT; 0 = no contraction, 5 = normal strength), compared with the contralateral side.
Assessed at 1 week, 1 month, 3 months, 6 months, and 12 months postoperatively
Patellar Height (Insall-Salvati Index)
Time Frame: Assessed at 1 month, 3 months, 6 months, and 12 months postoperatively
Ratio of patellar tendon length to patellar length measured on lateral knee radiographs (normal range 0.8-1.2).
Assessed at 1 month, 3 months, 6 months, and 12 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wei Xu, Dr, Fuzhou University Affiliated Provincial Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2024

Primary Completion (Estimated)

February 28, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

November 17, 2025

First Submitted That Met QC Criteria

November 21, 2025

First Posted (Actual)

November 25, 2025

Study Record Updates

Last Update Posted (Actual)

November 25, 2025

Last Update Submitted That Met QC Criteria

November 21, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared. Only aggregated study results and summary statistics will be made available through publications and conference presentations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patella Fracture

Clinical Trials on High-Strength Suture Modified Tension Band Fixation

Subscribe